pharma · Alagille Syndrome · Progressive Familial Intrahepatic Cholestasis (PFIC) · MIRM
Mirum Pharmaceuticals International
Mirum Pharmaceuticals International B.V.
Mirum Pharmaceuticals International clinical programs — 25 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 989 E Hillsdale Blvd., Suite 300, Foster City, CA 94404, US
- Founded
- 2018
- Employees
- 436
- Programs
- 25
- Drugs
- 10
- Patents
- 4
Mirum Pharmaceuticals International projects
25 ClinicalTrials.gov programs sponsored by Mirum Pharmaceuticals International.
Mirum Pharmaceuticals International has 25 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Blinded CDCA 250 mg TID
Mirum Pharmaceuticals International B.V.
CTX
1 trial -
Brelovitug (BJT-778)
Mirum Pharmaceuticals International B.V.
Chronic Hepatitis D
1 trial -
Brelovitug 300 mg
Mirum Pharmaceuticals International B.V.
Chronic Hepatitis D Infection
3 trials -
Cholic Acid
Mirum Pharmaceuticals International B.V.
Bile Acid Synthesis Defect
1 trial -
Cholic Acids
Mirum Pharmaceuticals International B.V.
Infantile Refsum's Disease
1 trial -
Cholic acid
Mirum Pharmaceuticals International B.V.
Inborn Errors of Bile Acid Synthesis
1 trial -
Maralixibat
Mirum Pharmaceuticals International B.V.
Progressive Familial Intrahepatic Cholestasis (PFIC)
3 trials -
Maralixibat
Mirum Pharmaceuticals International B.V.
Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC)
1 trial -
LUM001
Mirum Pharmaceuticals International B.V.
Primary Biliary Cirrhosis
1 trial -
LUM001
Mirum Pharmaceuticals International B.V.
Alagille Syndrome
2 trials -
LUM001
Mirum Pharmaceuticals International B.V.
PBC
1 trial -
LUM001
Mirum Pharmaceuticals International B.V.
Primary Sclerosing Cholangitis (PSC)
1 trial -
LUM001 (Maralixibat)
Mirum Pharmaceuticals International B.V.
Progressive Familial Intrahepatic Cholestasis (PFIC)
1 trial -
LUM001 (Maralixibat)
Mirum Pharmaceuticals International B.V.
Alagille Syndrome
3 trials -
Low dose of MRM-3379
Mirum Pharmaceuticals International B.V.
Fragile X Syndrome
1 trial -
Maralixibat
Mirum Pharmaceuticals International B.V.
Intrahepatic Cholestasis of Pregnancy
1 trial -
Maralixibat
Mirum Pharmaceuticals International B.V.
Progressive Familial Intrahepatic Cholestasis
1 trial -
Maralixibat
Mirum Pharmaceuticals International B.V.
Biliary Atresia
1 trial -
Maralixibat
Mirum Pharmaceuticals International B.V.
Cholestatic Liver Disease
1 trial -
SHP626
Mirum Pharmaceuticals International B.V.
Non-Alcoholic Steatohepatitis
3 trials -
Volixibat
Mirum Pharmaceuticals International B.V.
Intrahepatic Cholestasis of Pregnancy
1 trial -
Volixibat
Mirum Pharmaceuticals International B.V.
Primary Sclerosing Cholangitis
1 trial -
Volixibat
Mirum Pharmaceuticals International B.V.
Primary Biliary Cholangitis
1 trial -
Placebo
Mirum Pharmaceuticals International B.V.
Healthy Volunteers
1 trial -
Livmarli Oral Product
Mirum Pharmaceuticals International B.V.
Alagille Syndrome
1 trial
Frequently asked questions
How many clinical projects does Mirum Pharmaceuticals International have?
25 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.